The Peptide CommonsEst. May 2024
Independent. We sell nothing and are affiliated with no manufacturer or pharmacy. Every moderation action is logged in public
Clinical · Comorbidities

Heart failure with preserved ejection fraction: symptom endpoints

IT
integrator_traceTL2Member7 Jun 2026#1

Heart failure with preserved ejection fraction: symptom endpoints — setting out what I have, and where I think it stops being reliable.

Heart failure with preserved ejection keeps being re-asked here and I think that is because the answer is conditional and the conditions never travel with it.

Attempting to write the conditional version down properly. Corrections welcome and expected — I would like this to end up as a maintained page rather than a fifth thread.

27 likes 2mo
SG
s.grigorescuTL2Member11 Jun 2026#2

Seconded. It reads as careful rather than confident, which is the right register.

5 likes 2mo
SR
sa.rasmussenTL213 Jun 2026#3

The most common failure in this subcategory is answering a specific person's question as though it were the general one. They deserve different answers.

A partial answer, offered because a partial answer beats none.

0 likes 1mo
FV
first_vialTL1Member15 Jun 2026#4

Picking up post #3: that is the part I would want checked first.

What would change my mind on heart failure with preserved ejection is a second dataset collected by someone with no stake in the first. Until then I hold it loosely and I would rather say so than pretend to more.

0 likes 1mo
II
i.ilungaTL217 Jun 2026#5
s.grigorescu, post #2: Seconded. It reads as careful rather than confident, which is the right register. Go to post

Where the honest answer is "nobody knows", giving it plainly is more useful than a confident synthesis of mechanism and anecdote.

Reading it back, the second half matters more than the first.

20 likes in reply to #2 1mo
SL
sleep_logTL2Regular19 Jun 2026#6

Two claims get bundled together under heart failure with preserved ejection and they need separating. The descriptive one — this is what was observed — is usually well supported. The causal one — this is why — usually is not.

Almost every disagreement in threads like this one dissolves once you say which of the two you are making.

9 likes 1mo
JB
j.bhattacharyaTL221 Jun 2026#7

Post #3 describes the usual case. This is about the unusual one.

On heart failure with preserved ejection, the part that usually goes wrong is that the question is asked as though it has one answer. It has a range, and the width of the range is the interesting bit.

If you can post the two or three numbers you are working from, several people here will check the arithmetic rather than argue about the conclusion.

2 likes 1mo
SC
s.chowdhuryTL3Regular23 Jun 2026#8

Adding the measurement that post #7 says would settle it.

A condition that affects nutrition or absorption changes the calculus around a treatment that reduces intake, and that interaction is mostly unstudied.

0 likes 1mo
AI
an.ibarraTL224 Jun 2026#9
FN
formulary_notesTL3Regular26 Jun 2026 · edited#10
first_vial, post #4: Picking up post #3: that is the part I would want checked first. What would change my mind on heart failure with preserved ejection is a second dataset collected by someone with no stake in the first. Until then I hold it loosely and I would rather say so than pretend to more. Go to post

Building on post #7 rather than restating it.

Heart failure with preserved ejection has been discussed here with more heat than it deserves, mostly because two definitions have been in play the whole time.

1 like in reply to #4 1mo
IT
impurity_tableTL3Analytical chemist27 Jun 2026#11

Post #8 answers the question as asked. The question underneath it is different.

Bariatric surgery history: altered anatomy after surgery affects absorption. That matters for oral medications and for reconstituted solutions. Discussing specific medications and doses with a clinician familiar with bariatric surgery is prudent.

Scoping that to what I have actually seen rather than what I have read.

3 likes 30d
SO
s.ostergaardTL229 Jun 2026 · edited#12

I read post #10 twice before replying, because I had assumed the opposite.

The practical value of this subcategory is helping somebody frame the question they take to an appointment, and that is worth being explicit about.

Second-hand, so weight it accordingly.

10 likes 29d
CR
compounding_ruthTL4Pharmacist1 Jul 2026#13
sa.rasmussen, post #3: The most common failure in this subcategory is answering a specific person's question as though it were the general one. They deserve different answers. A partial answer, offered because a partial answer beats none. Go to post

The most common failure in this subcategory is answering a specific person's question as though it were the general one. They deserve different answers.

Posting it because the silence on this was starting to look like agreement.

23 likes in reply to #3 27d
IN
i.norgaardTL22 Jul 2026#14

An update on my earlier heart failure with preserved ejection post: the pattern held for another six weeks and then stopped, which I did not predict and cannot explain.

0 likes 26d
B
batchlogTL3Regular4 Jul 2026#15

That is clearer than the version I had in my head. Thank you.

6 likes 24d
CC
c.chowdhuryTL25 Jul 2026#16
s.ostergaard, post #12: I read post #10 twice before replying, because I had assumed the opposite. The practical value of this subcategory is helping somebody frame the question they take to an appointment, and that is worth being explicit about. Second-hand, so weight it accordingly. Go to post

Coming back to post #14, because the follow-up matters more than the original answer.

I think the heart failure with preserved ejection question is answerable and has not been answered, which is a more optimistic position than most of this thread.

16 likes in reply to #12 23d
BV
bias_varianceTL4Biostatistician7 Jul 2026#17
s.grigorescu, post #2: Seconded. It reads as careful rather than confident, which is the right register. Go to post

This follows post #16 rather than contradicting it.

Post-authorisation safety studies are the place where under-studied populations eventually appear, and they are public.

Worth checking against a second source before it gets quoted onward.

31 likes in reply to #2 21d
DF
d.ferreiraTL28 Jul 2026#18

Heart failure with preserved ejection would be much easier to settle if anyone reported the denominator. Almost nobody reports the denominator.

0 likes 20d
JB
j.baptistaTL29 Jul 2026#19

Small methodological point on heart failure with preserved ejection: repeating a measurement is cheap and resolves most of what is being argued about here at no cost to anyone.

0 likes 19d
MR
m.rasmussenTL211 Jul 2026#20
integrator_trace, post #1: Heart failure with preserved ejection fraction: symptom endpoints — setting out what I have, and where I think it stops being reliable. Heart failure with preserved ejection keeps being re-asked here and I think that is because the answer is conditional and the conditions never travel with it. Attempting to write the conditional version… Go to post

Asking about a population rather than about yourself is a legitimate framing and generally gets a better answer, because the general case is answerable.

3 likes in reply to #1 17d
SV
sa.vogelTL212 Jul 2026#21

Everything in post #19 holds. The case it does not cover is the one I have.

Where I have landed on heart failure with preserved ejection, having got it wrong once in public: the direction is clear, the magnitude is not, and anyone quoting a precise magnitude has borrowed it from somewhere that did not measure it.

7 likes 16d
BR
buffer_reviewTL3Regular13 Jul 2026#22

Narrowing post #19, because the general version has more than one answer.

The confident answers on heart failure with preserved ejection and the well-sourced answers are not the same answers, which is the most useful thing I have learned reading this category.

1 like 14d
HB
h.bhattacharyaTL215 Jul 2026#23

Gastrointestinal conditions interact with a mechanism that slows gastric emptying in ways that are plausible and largely unstudied.

This is the version I would want a new member to read first.

33 likes 13d
C
CSagredoTL3Regular16 Jul 2026#24
s.grigorescu, post #2: Seconded. It reads as careful rather than confident, which is the right register. Go to post

Where somebody is on several medicines, the interaction question and the comorbidity question are entangled and both belong with a pharmacist.

17 likes in reply to #2 12d

Suggested topics

TopicParticipantsRepliesViewsActivity
Hepatic steatosis: what the MASH trial evidence supports
Hepatic steatosis: what the MASH trial evidence supports — setting out what I have, and where I think it stops being reliable. Trying to work out what would count as evidence on hepatic steatosis, before…
CMPCNLSMA+77 83 950 13mo
Revisiting: Heart failure with preserved ejection fraction: symptom endpoints
On the subject in the title: Revisiting: Heart failure with preserved ejection fraction: symptom endpoints Working notes rather than a conclusion. Working notes on Heart failure with preserved ejection rather…
SPDBOCASCN+4 8 43k 17mo
About the Comorbidities category
Type 2 diabetes, hepatic steatosis, sleep apnoea, cardiovascular and renal disease. This post is a community wiki: any member at trust level 3 or above can edit it, and every edit is recorded with its author…
DOJMKHBMCE 4 16k 12h
Type 2 diabetes and the largest part of the evidence base — does this still hold?
Type 2 diabetes and the largest part of the evidence base — does this still hold? I have a specific reason for asking rather than idle curiosity, and the context is below. Trying to work out what would count…
NANKEML+18 25 1.7k 22mo
Second pass at: Obstructive sleep apnoea and a hard endpoint in this class
Second pass at: Obstructive sleep apnoea and a hard endpoint in this class — setting out what I have, and where I think it stops being reliable. Something about Obstructive sleep apnoea does not reconcile and…
SVCLRF 2 726 14mo

Related topics — sharing the tags type 2 diabetes, obstructive sleep apnoea, MASH / hepatic steatosis

TopicParticipantsRepliesViewsActivity
How to ask for a dose change without antagonising anyone — what changed since
How to ask for a dose change without antagonising anyone — what changed since — that is the question, and I have not found it answered plainly anywhere I have looked. A question about how to describe…
RVHKTDESAA+81 92 10k 20mo
Electrolyte supplements: which ones do anything — a second dataset
Electrolyte supplements: which ones do anything — a second dataset Writing it up because I had to work it out twice and would rather nobody else did. Posting a small dataset on Electrolyte supplements. It is…
HDGOVT 2 59k 15mo
Asking about a compound your prescriber has not heard of — one year on
On the subject in the title: Asking about a compound your prescriber has not heard of — one year on Working notes rather than a conclusion. A question about how to describe something to a clinician rather…
ESMHKDOBSG+11 15 3.7k 19mo
Discussing something you have already been doing — the long version
Discussing something you have already been doing — the long version Writing it up because I had to work it out twice and would rather nobody else did. A question about how to describe something to a clinician…
ITATALENG+14 18 58k 12mo
Second pass at: Semaglutide and alcohol: what is actually documented
Second pass at: Semaglutide and alcohol: what is actually documented Writing it up because I had to work it out twice and would rather nobody else did. Two things I would like separated before anyone answers…
IBDNOFID+15 19 4.4k 13mo